BioVaxys Files US Patent Application for Pan-Sarbecovirus Vaccine
VANCOUVER, BC, Oct. 20, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV), (FRA:5LB), (OTCQB:BVAXF) ("BioVaxys" or "Company"), announced today that it has filed with the United States Patent & Trademark Office ("USPTO") a provisional patent application for its haptenized viral antigen vaccine platform to elicit a broad cross-reactive immune response against...
Creatus Biosciences Inc. acquires the exclusive option to IP Assets from Stora Enso to Commercialize Xylitol Bioproduction from Biomass
VANCOUVER, BC, Oct. 20, 2021 /PRNewswire/ -- Creatus Biosciences Inc. ("Creatus") have signed a purchase agreement with Virdia, LLC ("Virdia"), a wholly-owned subsidiary of Stora Enso Oyj ("Stora Enso") to commercialize end-to-end production of xylitol by fermentation from biomass. The agreement sees Creatus acquire the exclusive option to all IP assets...
Senhwa Presents Positive Initial Data from Phase 2 Clinical Trial of Silmitasertib (CX-4945) in Moderate COVID-19 Patients At the ISIRV-WHO Conference
Statistically significant 133% faster time to COVID-19 clinical symptoms recovery versus standard of care (SOC)/best supportive care. Statistically significant 114% faster time to reach EQ-5D-5L Q6 ≥ 90% versus SOC/best supportive care. Statistically significant 57% faster time to normalization of COVID-19 related clinical signs versus SOC/best supportive care. ...
Seoul Gangnam-gu kicks off 2021 Medical Tourism Brand Festa
SEOUL, South Korea, Oct. 20, 2021 /PRNewswire/ -- Gangnam-gu (the Mayor of Gangnam-gu, Jeong sungun) is holdiong the '2021 Gangnam Medical Festa' in Nonhyeon-ro and Sinsa-ro areas for the month of October with the theme of 'Gangnam connected to the world, Gangnam, a healthy medical city'. 2021 GANGNAM MEDI TOUR BRAND FESTA This event was arranged to...
NFL Alumni Performance Labs Forms Exclusive Partnership with to Deliver Best-in-Class Predictive Vital Sign Analytics
The Singapore HealthTech company was chosen after NFLA's year-long global study involving trials with selected technology providers The partnership marks a significant validation of the company's technology in the US in elevating sports performance science Nervotec also advances the development of remote patient monitoring technologies with the application of predictive vital sign analytics SINGAPORE, Oct....
HistoIndex and Galecto to Collaborate on Galecto’s Phase 2a MYLOX-1 Clinical Trial to Advance Myelofibrosis Assessment with AI-based Stain-free Digital Pathology
SINGAPORE, Oct. 20, 2021 /PRNewswire/ -- HistoIndex, a global leading artificial intelligence digital pathology (AI-DP) provider, has announced a collaboration with Galecto, Inc., a biotechnology company focused on the development of novel treatments for fibrosis and cancer. This collaboration expands HistoIndex's portfolio of fibrosis assessment outside of Nonalcoholic Steatohepatitis (NASH) and other liver diseases. The proprietary stain-free imaging...
Xinhua Silk Road: 52nd Zhangshu National Traditional Chinese Materia Medica Trade Fair kicks off in E. China’s Jiangxi
BEIJING, Oct. 20, 2021 /PRNewswire/ -- The 52nd Zhangshu National Traditional Chinese Materia Medica Trade Fair opened in Zhangshu, a country-level city in east China's Jiangxi Province on Saturday. Photo shows the opening ceremony of the 52nd Zhangshu National Traditional Chinese Materia Medica Trade Fair held in Zhangshu, a country-level city in east China's Jiangxi Province on October...
A Hypercompact CRISPR Technology Developed by GenKOre is deemed a Potential Game Changer in Gene Therapy.
DAEJEON, South Korea, Oct. 20, 2021 /PRNewswire/ -- On September 2, 2021, a scientific paper from GenKOre on the new hypercompact CRISPR system called CRISPR/Cas12f-GE was published in an online issue of Nature Biotechnology (IF 54.9), one of the world's top-tier biotechnology journals. gene scissor technology For effective gene therapy,...
Getinge Q3 Report 2021: “Strong order intake and our remediation measures completed in Germany”
GOTHENBURG, Sweden, Oct. 20, 2021 /PRNewswire/ -- "Organic order intake increased by more than 20% in the third quarter, with a strong performance in all business areas and regions," says Mattias Perjos, President & CEO at Getinge. "Our cash flow remains strong, meaning that we have strengthened our solid financial position." Getinge's order growth was strong compared with both...
Action for bone health is needed now more than ever, urges IOF
NYON, Switzerland, Oct. 20, 2021 /PRNewswire/ -- A backlog in osteoporosis assessments, treatment delays, and sedentary indoor lifestyles: these are just several ways in which the Covid-19 pandemic has impacted bone health and disrupted global osteoporosis care. Osteoporosis is a common bone disorder that leads to weak and fragile bones which fracture easily. An osteoporotic fracture typically occurs as...
